×
About 9,145 results

ALLMedicine™ Renal Transplantation Center

Research & Reviews  3,277 results

Anakinra vs Prednisone to Treat Gout Flare in Patients With Chronic Kidney Disease Stage 4/5 or Renal Transplantation
https://clinicaltrials.gov/ct2/show/NCT04844814

May 13th, 2022 - The study will include 234 gouty patients with CKD 4/5 or renal transplantation with gout flare This study will include the following visits: - Selection/inclusion visit (V0): Patient with gout flare and CKD 4/5 or renal transplantation will be in...

The experience of hereditary apolipoprotein A-I amyloidosis at the UK National Amyloido...
https://doi.org/10.1080/13506129.2022.2070741
Amyloid : the International Journal of Experimental and C... Cohen OC, Blakeney IJ et. al.

May 4th, 2022 - Hereditary apolipoprotein A-I (AApoAI) amyloidosis is a rare heterogeneous disease with variable age of onset and organ involvement. There are few series detailing the natural history and outcomes of solid organ transplantation across a range of c...

Analytical and clinical validation of dried blood spot and volumetric absorptive micros...
https://doi.org/10.1016/j.clinbiochem.2022.04.014
Clinical Biochemistry; Mathew BS, Mathew SK et. al.

May 2nd, 2022 - Serial monitoring of tacrolimus and serum creatinine after renal transplantation is of vital importance. In this study, a liquid chromatography-tandem mass spectrometry (LC-MS/MS) assay for the estimation of tacrolimus and creatinine, obtained fro...

Polycystic Kidney/Liver Disease.
https://doi.org/10.1016/j.cld.2022.01.009
Clinics in Liver Disease; Roediger R, Dieterich D et. al.

Apr 30th, 2022 - Autosomal dominant polycystic kidney disease (ADPKD) is a genetic disorder that leads to chronic kidney disease and end-stage kidney disease (ESKD). Polycystic liver disease (PCLD) is the most common extrarenal manifestation of ADPKD. Though isola...

Passenger lymphocyte syndrome in renal transplantation: A systematic review of publishe...
https://doi.org/10.1016/j.trim.2022.101605
Transplant Immunology; Zhao H, Ding Z et. al.

Apr 30th, 2022 - Passenger lymphocyte syndrome (PLS) is an immune-mediated hemolysis that occurs after ABO-mismatched kidney transplantation. PLS is caused by donor lymphocytes producing antibodies to recipient red blood cells, resulting in hemolysis. The incidenc...

see more →

Guidelines  10 results

Management of obesity in kidney transplant candidates and recipients: A clinical practi...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712154
Nephrology, Dialysis, Transplantation : Official Publicat... Oniscu GC, Abramowicz D et. al.

Nov 18th, 2021 - The clinical practice guideline Management of Obesity in Kidney Transplant Candidates and Recipients was developed to guide decision-making in caring for people with end-stage kidney disease (ESKD) living with obesity. The document considers the c...

Clinical practice guidelines standardisation of immunosuppressive and anti-infective dr...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447621
BMC Nephrology; Dudley J, Christian M et. al.

Sep 18th, 2021 - Clinical practice guidelines standardisation of immunosuppressive and anti-infective drug regimens in UK paediatric renal transplantation: the harmonisation programme.|2021|Dudley J,Christian M,Andrews A,Andrews N,Baker J,|administration & dosage,...

Clinical practice recommendations for growth hormone treatment in children with chronic...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136166
Nature Reviews. Nephrology; Drube J, Wan M et. al.

Jun 15th, 2019 - Achieving normal growth is one of the most challenging problems in the management of children with chronic kidney disease (CKD). Treatment with recombinant human growth hormone (GH) promotes longitudinal growth and likely enables children with CKD...

European Association of Urology Guidelines on Renal Transplantation: Update 2018.
https://doi.org/10.1016/j.euf.2018.07.014
European Urology Focus; Rodríguez Faba O, Boissier R et. al.

Jul 24th, 2018 - The European Association of Urology (EAU) panel on renal transplantation (RT) has released an updated version of the RT guidelines. To present the 2018 EAU guidelines on RT. A broad and comprehensive scoping exercise was performed, encompassing al...

Diagnosis and management of glycogen storage disease type I: a practice guideline of th...
https://doi.org/10.1038/gim.2014.128
Genetics in Medicine : Official Journal of the American C... Kishnani PS, Austin SL et. al.

Oct 31st, 2014 - Glycogen storage disease type I (GSD I) is a rare disease of variable clinical severity that primarily affects the liver and kidney. It is caused by deficient activity of the glucose 6-phosphatase enzyme (GSD Ia) or a deficiency in the microsomal ...

see more →

Drugs  140 results see all →

Clinicaltrials.gov  145 results

Anakinra vs Prednisone to Treat Gout Flare in Patients With Chronic Kidney Disease Stage 4/5 or Renal Transplantation
https://clinicaltrials.gov/ct2/show/NCT04844814

May 13th, 2022 - The study will include 234 gouty patients with CKD 4/5 or renal transplantation with gout flare This study will include the following visits: - Selection/inclusion visit (V0): Patient with gout flare and CKD 4/5 or renal transplantation will be in...

Study of Combined Kidney and Blood Stem Cell Transplant From a Brother or Sister Donor
https://clinicaltrials.gov/ct2/show/NCT03707262

Apr 13th, 2022 - In spite of the pronounced benefit of kidney transplantation in prolonging survival and improving the quality of life of patients with end stage renal disease, it is still hampered by the risk of graft rejection and the need for lifelong immunosup...

Erector Spinae Plane Block in Renal Transplantation Donors
https://clinicaltrials.gov/ct2/show/NCT04863716

Apr 7th, 2022 - Erector Spina Plan Block (ESPB) is a relatively new, easy-to-apply and safe regional anesthesia technique used to provide postoperative analgesia in various surgeries. Studies showing the clinical benefits of Erector Spina Plan block in renal tran...

Pilot Study: Interest of Belatacept as a Non-nephrotoxic Immunosuppressive Treatment in Cardiac Transplant Patients at Risk of Chronic Renal Failure (BELACOEUR)
https://clinicaltrials.gov/ct2/show/NCT04180085

Mar 25th, 2022 - Heart transplantation (TC) is the standard treatment for terminal heart failure. Chronic kidney disease (CKD) is a common complication responsible for increased mortality and morbidity. The main risk factors for progression to CKD are advanced age...

Comparison between2 Drugs in Lupus Nephritis
https://clinicaltrials.gov/ct2/show/NCT04424602

Feb 15th, 2022 - Systemic lupus erythematosus (SLE), also known simply as lupus, is an autoimmune disease in which the body's immune system mistakenly attacks healthy tissue in many parts of the body. Symptoms vary between people and may be mild to severe. common ...

see more →

News  86 results

Empagliflozin Win in EMPEROR-Preserved HF, but Renal Outcomes Puzzle
https://www.medscape.com/viewarticle/957997

Sep 1st, 2021 - The featured report from the 6,000-patient EMPEROR-Preserved trial at the virtual annual congress of the European Society of Cardiology drew lots of attention for its headline finding: the first unequivocal demonstration that a medication, empagli...

Prominent Nephrologist, Mount Sinai Chair of Medicine Dies at 56
https://www.medscape.com/viewarticle/954151

Jul 2nd, 2021 - Dr Barbara T. Murphy Barbara T. Murphy, MD, renowned nephrologist and professor of medicine at Mount Sinai School of Medicine in New York City, died June 30 at age 56, Mount Sinai leadership announced in a memo circulated internally.   She was pre...

Patient With Post-COVID-19 Cholangiopathy Undergoes Successful Liver Transplant
https://www.medscape.com/viewarticle/948012

Mar 25th, 2021 - NEW YORK (Reuters Health) - A 47-year-old man who recovered from acute respiratory distress syndrome related to COVID-19 and then went on to develop end-stage liver disease is doing well after liver transplantation, according to a new report. "Liv...

Severe renal arteriosclerosis may indicate cardiovascular risk in lupus nephritis
https://www.mdedge.com/rheumatology/article/234917/lupus-connective-tissue-diseases/severe-renal-arteriosclerosis-may
Heidi Splete

Jan 22nd, 2021 - Severe renal arteriosclerosis was associated with a ninefold increased risk of atherosclerotic cardiovascular disease in patients with lupus nephritis, based on data from an observational study of 189 individuals. Mohammed Haneefa Nizamudeen/Getty.

Bristol-Myers Squibb
https://www.onclive.com/view/onc-bristol

Dec 5th, 2020 - Bristol-Myers Squibb is a leading provider of medicines to fight cancer, cardiovascular and infectious diseases—including HIV/AIDS—and serious mental illness. Bristol-Myers Squibb’s other businesses include Mead Johnson Nutritionals, best kn...

see more →